High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF

被引:126
作者
Hoffmann, Andreas-Claudius [1 ,2 ]
Mori, Ryutaro
Vallbohmer, Daniel
Brabender, Jan
Klein, Ellen
Drebber, Uta
Baldus, Stephan E.
Cooc, Janine
Azuma, Mizutomo
Metzger, Ralf
Holscher, Arnulf H.
Danenberg, Kathleen D.
Prenzel, Klaus L.
Danenberg, Peter V.
机构
[1] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA
[2] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA
来源
NEOPLASIA | 2008年 / 10卷 / 07期
关键词
D O I
10.1593/neo.08292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: Pancreatic cancer still has one of the worst prognoses in gastrointestinal cancers with a 5-year survival rate of 5%, making it necessary to find markers or gene sets that would further classify patients into different risk categories and thus allow more individually adapted multimodality treatment regimens. In this study, we investigated the prognostic values of HIF1a, bFGF, VEGF, and PDGFA gene expressions as well as their interrelationships. EXPERIMENTAL DESIGN: Formalin-fixed paraffin-embedded tissue samples were obtained from 41 patients with pancreatic adenocarcinoma (age, 65; range, 34-85 years). After laser capture microdissection, direct quantitative real-time reverse transcription-polymerase chain reaction assays were performed in triplicates to determine HIF1a, PDGFA, VEGF, and bFGF gene expression levels. Multivariate Cox proportional hazards regression analysis was used to assess the impact of HIF1a gene expression on prognosis. RESULTS: HIF1a was significantly correlated to every gene we tested: bFGF (P=.04), VEGF (P=.02), and PDGFA (P=.03). Tumor size, P=.04, and high HIF1a mRNA expression (cutoff, 75th percentile) had a significant impact on survival, P=.009 (overall model fit, P=.02). High HIF1a expression had a sensitivity of 87.1% and a specificity of 55.6% for the diagnosis short (< 6 months) versus long (6-60 months) survival. CONCLUSIONS: Measuring PDGFA, bFGF, and HIF1a expression may contribute to a better understanding of the prognosis of patients with pancreatic cancer and may even play a crucial role for the distribution of patients to multimodal therapeutic regimens. Larger studies including patients treated with actual chemotherapeutics seem to be warranted.
引用
收藏
页码:674 / 679
页数:6
相关论文
共 27 条
  • [21] Targeting of the VHL-hypoxia-inducible factor-hypoxia-induced gene pathway for renal cell carcinoma therapy
    Sosman, JA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11): : 2695 - 2702
  • [22] Sun HC, 2007, INT J ONCOL, V30, P1359
  • [23] Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer
    Tao J.
    Li T.
    Li K.
    Xiong J.
    Yang Z.
    Wu H.
    Wang C.
    [J]. Journal of Huazhong University of Science and Technology, 2006, 26 (5): : 562 - 564
  • [24] Molecular determinants of cetuximab efficacy
    Vallböhmer, D
    Zhang, W
    Gordon, M
    Yang, DY
    Yun, J
    Press, OA
    Rhodes, KE
    Sherrod, AE
    Iqbal, S
    Danenberg, KD
    Groshen, S
    Lenz, HJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3536 - 3544
  • [25] Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis
    Wang, Feng
    Li, Shu Shun
    Segersvard, Ralf
    Strommer, Lisa
    Sundqvist, Karl-Gosta
    Holgersson, Jan
    Permert, Johan
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (02) : 469 - 477
  • [26] HYPOXIA-INDUCIBLE FACTOR-1 IS A BASIC-HELIX-LOOP-HELIX-PAS HETERODIMER REGULATED BY CELLULAR O-2 TENSION
    WANG, GL
    JIANG, BH
    RUE, EA
    SEMENZA, GL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) : 5510 - 5514
  • [27] Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma
    Worden, B
    Yang, XP
    Lee, TL
    Bagain, L
    Yeh, NT
    Cohen, JG
    Van Waes, C
    Chen, Z
    [J]. CANCER RESEARCH, 2005, 65 (16) : 7071 - 7080